Vitalograph Celebrates Two Years of Unprecedented PFT Growth as Morgan Scientific Becomes Vitalograph

US PFT sales nearly double since 2024 as Vitalograph brings its North American business under one name.

HAVERHILL, Mass. and ENNIS, Ireland, Nov. 5, 2026 /PRNewswire/ -- Vitalograph, a global leader in respiratory diagnostic solutions for healthcare and clinical trials, has seen unprecedented growth in the two years since it acquired Morgan Scientific, driven by surging demand for its pulmonary function testing (PFT) solutions. In the US alone, yearly PFT sales have nearly doubled since 2024. Building on that success, Vitalograph today announced the natural next step: Morgan Scientific, based in Haverhill, Massachusetts, is now Vitalograph.

The 2024 acquisition brought together Vitalograph's respiratory diagnostics expertise and Morgan Scientific's PFT software, and customers across North America have embraced the result. At the heart of that growth is comPAS™, which brings pulmonary function testing devices, software and expertise together in one integrated respiratory diagnostics system. Now under a single name, Vitalograph is ready to build on that success with every new customer, partner and installation.

Frank Keane, CEO of Vitalograph, said: "This is a really exciting time for Vitalograph. The growth we've seen in pulmonary function testing over the past two years has exceeded our expectations, and the US is one of our fastest-growing markets for comPAS PFT solutions. We've been committed to the US since we opened our first facility in Kansas City in 1971, and we've continued to invest in and expand our operations here ever since. Bringing everyone together under the Vitalograph name is the natural next step, and it gives our customers one clear partner across the full range of respiratory diagnostics. In advanced pulmonary function testing, we're only just getting started."

Gareth Morgan, Executive Vice President of Vitalograph US, said: "What we've achieved together in two years is remarkable. Demand for our PFT solutions has grown faster than any of us imagined, and the Morgan Scientific team has been pivotal to that success. Taking the Vitalograph name is the natural next step. With the strength of a global respiratory company behind us, I can't wait to see what we achieve next for the clinicians and patients we serve."

One Vitalograph

The new name also celebrates how Vitalograph works today. Since 2024, teams in the US, UK, Ireland, Germany and the Middle East have come together around a shared mission and shared values. Now every employee, in every region and function, shares one identity, one story and one purpose: to enable a deeper understanding of lung health and better outcomes for patients, everywhere Vitalograph operates.

This is a story of continuity and growth. The people, expertise and service that customers rely on stay the same, now with one name, one visual identity and one digital presence. Vitalograph is ready for an exciting next chapter across North America and beyond.

About Vitalograph

Vitalograph is a global leader in respiratory diagnostics and clinical trial services. Its full suite of respiratory diagnostic solutions spans everything from peak flow meters for personal monitoring of lung health to advanced body plethysmographs for in-depth respiratory function examination. Vitalograph also provides specialist clinical trial solutions to pharmaceutical and biotech companies running respiratory studies. Founded in the UK, Vitalograph has its main R&D, engineering and manufacturing facility in Ennis, Ireland, and US operations in Haverhill, Massachusetts, and Lenexa, Kansas (Kansas City). It also has offices in the UK, Germany and Dubai. Its solutions are used by healthcare professionals worldwide. Learn more at vitalograph.com.

Media contact

Laura Colleran, Global Marketing Communications Senior Manager, Vitalograph +353 (0)89 4727860, 426298@email4pr.com

SOURCE Vitalograph